Search for: "Hoffmann-La Roche" Results 81 - 100 of 181
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Jun 2011, 4:56 am by Marie Louise
(Patent Docs) Xeloda (Capecitabine) – US: Patent infringement complaint filed in response to Para IV certification: Hoffmann-La Roche Inc. v. [read post]
25 Jun 2012, 2:18 pm by Andrew Frisch
… In sum, we believe the relation back doctrine helps ensure the use of Rule 68 does not prevent a collective action from playing out according to the directives of § 216(b) and the procedures authorized by the Supreme Court in HoffmannLa Roche and further refined by courts applying this statute. [read post]
18 Oct 2010, 5:51 pm by Michael C. Smith
  (In doing so, the Court was careful to note that it did not take into consideration the presence of the 4 court files from the related Echostarcase, "which would have remained in California but for that litigation" citing In re Hoffmann-La Roche Inc., 587 F.3d 1333,1337 (Fed. [read post]
5 Jan 2011, 2:24 pm by Jason Rantanen
  Thus, just as transferring thousands of pages of relevant documents to the offices of litigation counsel in Texas in order to assert that the location of those documents favored non-transfer was entitled to no weight in In re Hoffmann-La Roche Inc., 587 F.3d 1333 (Fed. [read post]
7 Sep 2010, 6:10 pm by Kelly
Patent and Trademark Office et. al, (Prior Art) US: District Court New Jersey: Drug label may provide evidence of intent to induce infringement even though required by the FDA: Hoffmann-La Roche Inc. v. [read post]
15 Sep 2010, 2:40 am by Kelly
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US:… [read post]
8 Oct 2009, 6:05 am
Hoffmann-La Roche (Patent Docs) Razadyne (Galanthamine) - US: CAFC: You can’t rely on test results that weren’t available when your patent application was filed: Janssen Pharma and Synaptech v. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
16 Mar 2011, 3:50 am by Marie Louise
Actavis (Kluwer Patent Blog) Valsartan – Norway: Valsartan case goes on appeal: Novartis v Actavis (The SPC Blog) Xeloda (Capecitabine) – US: Hoffmann-La Roche files patent infringement complaint against Accord following Para IV challenge (Patent Docs) [read post]
7 Mar 2016, 1:55 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences.Never too late 83 [week ending on Sunday 14 February] – Indigenous IP | Arnold J's latest judgment flags down the iconic London black cab | Life of a national/EU trade mark ... in a map | A comprehensive… [read post]
23 Feb 2016, 1:53 am
Hoffmann-La Roche AG and Genentech Inc. [read post]
14 Mar 2016, 3:23 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences. [read post]
29 Mar 2007, 4:46 am
Hoffmann-La Roche Inc., 892 A.2d 694, (N.J. [read post]
27 Feb 2014, 9:38 am by Dennis Crouch
Cir. 2009) and In re Hoffmann-La Roche, 587 F.3d 1333 (Fed. [read post]
17 Aug 2012, 9:02 am by Julie Brook, Esq.
Hoffmann-La Roche, Inc. v Sperling (1989) 493 US 165, 169, 107 L Ed 2d 480, 110 S Ct 482. [read post]